.Merck & Co. is paying $700 million in advance to challenge Amgen in a blood cancer market. The o...
.Along With Gilead Sciences on the verge of an FDA decision for its own liver ailment medication sel...
.CEO David Ricks can observe the business putting together tents at basecamp behind Eli Lilly in an ...
.Bed mattress Liquidators has switched Entero Rehabs white colored as a slab. The collector purchase...
.Exelixis is actually giving up on its own cells variable (TF)- targeting antibody-drug conjugate af...
.Three weeks after Roche's Genentech unit walked away from an SHP2 prevention deal, Relay Therapy ha...
.Stoke Therapies' Dravet disorder drug has been actually freed from a predisposed hold, clearing the...
.Tough Biotech Partner Editor Gabrielle Masson provided the 2024 lesson of Strong 15 champions on th...
.Merck & Co. has actually quickly made back some of the expenses of its Weapon Therapies acquisti...
.After BioMarin administered a spring tidy of its pipeline in April, the firm has chosen that it lik...